[HTML][HTML] The clinical significance of MiR-148a as a predictive biomarker in patients with advanced colorectal cancer
M Takahashi, M Cuatrecasas, F Balaguer, K Hur… - 2012 - journals.plos.org
Aim Development of robust prognostic and/or predictive biomarkers in patients with
colorectal cancer (CRC) is imperative for advancing treatment strategies for this disease. We …
colorectal cancer (CRC) is imperative for advancing treatment strategies for this disease. We …
[引用][C] The Clinical Significance of MiR-148a as a Predictive Biomarker in Patients with Advanced Colorectal Cancer
M Takahashi, M Cuatrecasas, F Balaguer, K Hur… - PLoS ONE, 2012 - cir.nii.ac.jp
The Clinical Significance of MiR-148a as a Predictive Biomarker in Patients with Advanced
Colorectal Cancer | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細 …
Colorectal Cancer | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細 …
The Clinical Significance of MiR-148a as a Predictive Biomarker in Patients with Advanced Colorectal Cancer
M Takahashi, M Cuatrecasas, F Balaguer… - PLoS …, 2012 - tohoku.elsevierpure.com
Aim: Development of robust prognostic and/or predictive biomarkers in patients with
colorectal cancer (CRC) is imperative for advancing treatment strategies for this disease. We …
colorectal cancer (CRC) is imperative for advancing treatment strategies for this disease. We …
[PDF][PDF] The Clinical Significance of MiR-148a as a Predictive Biomarker in Patients with
M Takahashi, M Cuatrecasas, F Balaguer, K Hur… - 2012 - researchgate.net
Aim: Development of robust prognostic and/or predictive biomarkers in patients with
colorectal cancer (CRC) is imperative for advancing treatment strategies for this disease. We …
colorectal cancer (CRC) is imperative for advancing treatment strategies for this disease. We …
The Clinical Significance of MiR-148a as a Predictive Biomarker in Patients with Advanced Colorectal Cancer.
M Takahashi, M Cuatrecasas, F Balaguer, K Hur… - PLoS …, 2012 - search.ebscohost.com
Aim: Development of robust prognostic and/or predictive biomarkers in patients with
colorectal cancer (CRC) is imperative for advancing treatment strategies for this disease. We …
colorectal cancer (CRC) is imperative for advancing treatment strategies for this disease. We …
[PDF][PDF] The Clinical Significance of MiR-148a as a Predictive Biomarker in Patients with
M Takahashi, M Cuatrecasas, F Balaguer, K Hur… - 2012 - academia.edu
Aim: Development of robust prognostic and/or predictive biomarkers in patients with
colorectal cancer (CRC) is imperative for advancing treatment strategies for this disease. We …
colorectal cancer (CRC) is imperative for advancing treatment strategies for this disease. We …
[PDF][PDF] The Clinical Significance of MiR-148a as a Predictive Biomarker in Patients with
M Takahashi, M Cuatrecasas, F Balaguer, K Hur… - 2012 - Citeseer
Aim: Development of robust prognostic and/or predictive biomarkers in patients with
colorectal cancer (CRC) is imperative for advancing treatment strategies for this disease. We …
colorectal cancer (CRC) is imperative for advancing treatment strategies for this disease. We …
The clinical significance of MiR-148a as a predictive biomarker in patients with advanced colorectal cancer
M Takahashi, M Cuatrecasas Freixas… - PLoS One, 2012, vol. 7 …, 2012 - diposit.ub.edu
Aim: Development of robust prognostic and/or predictive biomarkers in patients with
colorectal cancer (CRC) is imperative for advancing treatment strategies for this disease. We …
colorectal cancer (CRC) is imperative for advancing treatment strategies for this disease. We …
[PDF][PDF] The Clinical Significance of MiR-148a as a Predictive Biomarker in Patients with
M Takahashi, M Cuatrecasas, F Balaguer, K Hur… - 2012 - pdfs.semanticscholar.org
Aim: Development of robust prognostic and/or predictive biomarkers in patients with
colorectal cancer (CRC) is imperative for advancing treatment strategies for this disease. We …
colorectal cancer (CRC) is imperative for advancing treatment strategies for this disease. We …
[HTML][HTML] The Clinical Significance of MiR-148a as a Predictive Biomarker in Patients with Advanced Colorectal Cancer
M Takahashi, M Cuatrecasas, F Balaguer, K Hur… - PLoS ONE, 2012 - ncbi.nlm.nih.gov
Aim Development of robust prognostic and/or predictive biomarkers in patients with
colorectal cancer (CRC) is imperative for advancing treatment strategies for this disease. We …
colorectal cancer (CRC) is imperative for advancing treatment strategies for this disease. We …